The FDA is tightening its regulatory policy around COVID vaccines with a new framework that raises the bar for approvals in ...

What's more, both FDA Commissioner Martin Makary, M.D., and longtime FDA oncology chief Richard Pazdur, M.D., have a new ...

As for what type of educational support they’re looking for, the most prevalent ask among HCPs was for clinical trial ...

President Donald Trump put the biopharma industry on its back foot earlier this month with his executive order on ...

SK Life Science is encouraging patients beetling down the long and winding road toward seizure-free life to switch gears. In ...

Given a list of 40 drugmakers, the respondents rated ViiV most highly in terms of corporate reputation, followed by ...

As Eli Lilly and Novo Nordisk continue to go in opposite directions in their diabetes and obesity market rivalry, so too have they changed positions in the annual IDEA Pharma Innovation Index, which ...

With $27 billion earmarked to expand its U.S. production footprint starting this year, Eli Lilly is busy scouting out ...

At long last, Novavax has secured a full FDA approval for its protein-based COVID-19 vaccine, though not in the broad ...

Eisai has put direct-to-consumer (DTC) advertising at the heart of its ongoing efforts to expand demand for Leqembi. | Eisai ...

On a mission to expand its recently approved Tryngolza beyond the rare genetic disorder familial chylomicronemia syndrome ...

AstraZeneca presented data from the phase 3 BATURA study which showed that use of Airsupra in those with mild asthma reduced the risk of severe exacerbations by 47% compared to albuterol, the ...